Viewing Study NCT06038695


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2025-12-29 @ 10:18 PM
Study NCT ID: NCT06038695
Status: WITHDRAWN
Last Update Posted: 2024-06-18
First Post: 2023-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immediate Implant Placement Using Volume-Stable Collagen Matrix Combined With rhPDGF-BB
Sponsor: I-Ching Wang
Organization:

Study Overview

Official Title: Ultrasound-based Imaging to Detect Early Changes of Hard and Soft Tissue Around Immediately Placed Implants With Volume-Stable Collagen Matrix Combined With rhPDGF-BB: Pilot Study
Status: WITHDRAWN
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Currently, there is no capacity for this project in the institute
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this study is to test a volume-stable collagen matrix in combination with recombinant human platelet-derived growth factor-BB, specifically in patients who have an immediate implant placement for teeth #5-#12.

The main question this study aims to answer is does the recombinant human platelet-derived growth factor-BB accelerate the formation of blood vessels and augment tissue volume around the immediate implant.

Participants will be asked to undergo immediate implant placement using volume-stable collagen matrix in combination with recombinant human platelet-derived growth factor-BB, as well as attend 11 study visits over the course of 1.25 years.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: